北美植物疫苗市场预测至 2028 年 - 按疫苗类型（细菌疫苗、病毒疫苗、寄生虫疫苗等）、来源（烟草植物、玉米、马铃薯等）和应用划分的 COVID-19 影响和区域分析（流感、寨卡病毒、埃博拉病毒、家禽疾病等）
市场介绍
北美植物疫苗市场分为美国、加拿大、墨西哥。 2021 年，北美可能会占据全球市场的重要份额。推动市场增长的关键因素是产品发布数量的增加以及研发活动的刺激。然而，在预测期内，市场可能会受到产品审批相关挑战以及植物疫苗生产的污染和环境风险等因素的限制。
<由于政府鼓励创新的政策、庞大的工业基础以及消费者的高购买力，北美成为新技术采用和增长的最重要地区之一，主要集中在美国等主要国家。美国和加拿大。因此，任何对工业增长的影响都会对该地区的经济增长产生负面影响。美国是全球受新冠肺炎 (COVID-19) 疫情影响最严重的国家。美国是一个著名的植物疫苗市场，因为主要市场参与者都位于美国。 2020 年，美国、加拿大和墨西哥的工厂和企业关闭对各个行业产生了负面影响。另一方面，由于新冠病毒数量不断增加，这场大流行病为植物疫苗市场的参与者提供了重要的增长机会。 19名患者。例如，一些企业正在研究和开发基于植物的 COVID-19 疫苗。例如，2021 年 6 月，生物技术创新者和生物制剂合同制造组织 iBio 宣布，针对 SARS-CoV-2 核衣壳蛋白（“N 蛋白”）的候选亚单位疫苗 IBIO-202 进行了临床前研究，表现出强大的、抗原特异性的记忆 T 细胞反应。植物疫苗的发展推动了市场的增长。
市场概况与动态
北美植物疫苗市场预计将从2021年的49866万美元增长到2028年的118106万美元；预计 2021 年至 2028 年复合年增长率为 13.1%。传染病是由细菌、病毒、寄生虫或真菌等病原微生物引起的，可以直接或间接从一个人传染给另一个人。这些疾病可分为三类——导致高死亡率的疾病、造成大量人口残疾的疾病，以及由于其快速和意外的传播而可能造成严重后果的疾病。许多主要的健康因素和传染病原因超出了卫生部门的直接控制范围。卫生和供水、环境和气候变化、教育、农业、贸易、旅游、交通、工业发展和住房是其他参与领域。
主要细分市场
北方美国植物疫苗市场按疫苗类型、来源、应用和国家细分。根据疫苗类型，北美植物疫苗市场分为细菌疫苗、病毒疫苗、寄生虫疫苗、植物源病毒样颗粒等。 2021年，细菌疫苗占据了最大的市场份额。根据来源，北美植物疫苗市场分为烟草植物、玉米、马铃薯等。 2021年，烟草植物疫苗占据了最大的市场份额。根据应用，北美植物疫苗市场分为流感、寨卡病毒、埃博拉病毒、家禽疾病、COVID-19等。 2021 年，流感细分市场占据最大市场份额。按国家/地区划分，北美植物疫苗市场分为美国、加拿大和墨西哥。 2021 年，美国占据最大市场份额。
主要来源和上市公司
准备本北美植物疫苗市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有英美烟草公司；创意生物实验室有限公司；弗劳恩霍夫； iBio公司；叶表达系统有限公司；莱尼奥生物；流明生物科学公司；苜蓿公司；和 ZYUS Life Sciences Inc.
购买报告的理由
- 了解北美植物疫苗市场格局并确定细分市场最有可能保证丰厚的回报。
- 了解北美植物疫苗市场不断变化的竞争格局，保持领先地位。
- 通过确定最有可能销售的细分市场，有效规划北美植物疫苗市场的并购和合作交易。
- 帮助通过对北美植物疫苗市场各个细分市场的市场表现进行敏锐和全面的分析，做出明智的业务决策。
- 获取 2021 年起各个细分市场的市场收入预测-2028年北美地区。
北美植物疫苗市场细分
北美植物疫苗市场 - 按疫苗类型
- 细菌疫苗
- 病毒疫苗
- 寄生虫疫苗
- 植物源性病毒样颗粒
- 其他
北美植物疫苗市场 - 按来源
- 烟草植物
- 玉米
- 马铃薯
- 其他
北美植物性疫苗市场 - 按应用
- 流感
- 寨卡病毒
- 埃博拉病毒
- COVID-19
- 家禽疾病
- 其他
北美植物疫苗市场 - 按国家/地区
- 美国
- 加拿大
- 墨西哥
北美植物疫苗市场 - 公司简介
- 英美烟草公司
- Creative Biolabs, Inc.
- 弗劳恩霍夫费朗霍夫
- iBio, Inc.
- Leaf Expression Systems Ltd.
- < span>LenioBio
- Lumen Bioscience, Inc.
- Medicago, Inc.
- ZYUS生命科学公司
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Plant-based Vaccines Market – By Vaccine Type
1.3.2 North America Plant-based Vaccines Market – By Source
1.3.3 North America Plant-based Vaccines Market – By Application
1.3.4 North America Plant-based Vaccines Market – By Country
2. North America Plant-based Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Plant-based Vaccines Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plant-Based Vaccines Witnessing Rising Number of Research & Development (R&D) Activities
5.1.2 Rising Instances of Infectious Diseases
5.2 Market Restraints
5.2.1 High Risk of Contamination Including Environmental Risks for Manufacturing Plant-Based Vaccines
5.3 Market Opportunities
5.3.1 Enhancements in Production of Plant-Based Vaccines
5.4 Future Trends
5.4.1 Rise in Product Approvals and Increase in Prevalence of Infectious Diseases
5.5 Impact Analysis
6. Plant-based Vaccines Market– North America Analysis
6.1 North America Plant-based Vaccines Market Revenue Forecast and Analysis
7. North America Plant-Based Vaccines Market Analysis – By Vaccine Type
7.1 Overview
7.2 North America Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Plant-based Vaccines Market Analysis – By Source
8.1 Overview
8.2 North America Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9. North America Plant-based Vaccines Market Analysis– by Application
9.1 Overview
9.2 North America Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.7 Covid-19
9.7.1 Overview
9.7.2 Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
10. North America Plant-based Vaccines Market – Country Analysis
10.1 North America: Plant based vaccines Market
10.1.1 Overview
10.1.2 North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Plant-Based Vaccines Market, by Source– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic On North America Plant-based Vaccines Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MEDICAGO, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 British American Tobacco p.l.c.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CREATIVE BIOLABS, INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 iBio, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 LENIOBIO
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lumen Bioscience, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LEAF EXPRESSION SYSTEMS LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ZYUS LIFE SCIENCES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 FRAUNHOFER CMB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 3. US Plant-Based Vaccines Devices Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Plant-Based Vaccines Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Recent organic developments in the Plant-based Vaccines Market
Table 11. Glossary of Terms, North America Plant-based Vaccines devices market
LIST OF FIGURES
Figure 1. North America Plant-based Vaccines Market Segmentation
Figure 2. North America Plant-based Vaccines Market Segmentation, By Country
Figure 3. North America Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in North America Plant-based Vaccines Market
Figure 5. US to Show Significant Growth during Forecast Period
Figure 7. North America PEST Analysis
Figure 8. North America Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. North America Plant-based Vaccines Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 11. North America Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 17. North America Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 22. North America Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. North America Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. North America Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 27. North America Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 28. North America: Plant-Based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 30. US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
Figure 34. Growth Strategies in the Plant-based Vaccines Market, 2019-2021- British American Tobacco p.l.c.
- Creative Biolabs, Inc.
- Fraunhofer
- iBio, Inc.
- Leaf Expression Systems Ltd.
- LenioBio
- Lumen Bioscience, Inc.
- Medicago, Inc.
- ZYUS Life Sciences Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America plant-based vaccines market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the plant-based vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution